IQX Limited

NSX:IQX ISIN:AU000000IQX4

IQX LimitedA member of The iQ Group Global, iQX Limited is an investment funds management company specialising in the bioscience sector that is committed to eradicating disease through capital investment.

 
   

News

IQX Limited (NSX:IQX) Worldwide License for Harvard Uni's eRapid Technology

🕔3/7/2022 10:30:00 AM 3229

iQX Limited (NSX:IQX) today announced it has received a worldwide license from Harvard's Office of Technology Development to commercialise diagnostic technology developed at the Wyss Institute for Biologically Inspired Engineering at Harvard University.

Read Full Article

IQX Limited (NSX:IQX) FDA Breakthrough Devices Designation

🕔12/13/2021 10:10:00 AM 4359

iQX Limited (NSX:IQX) has filed an application with the U.S Food and Drug Administration (FDA) for Breakthrough Device Designation.

Read Full Article

IQX Limited (NSX:IQX) Wyss Validation Study SARS-CoV-2

🕔11/11/2021 9:06:00 AM 3201

iQX Limited (NSX:IQX), on behalf of Life Science Biosensor Diagnostics Pty Ltd (LSBD), in which IQX holds 19% equity position, today announced the successful completion of a clinical validation study showcasing the efficacy of its rapid SARS-Cov-2 Antibody test.

Read Full Article

IQX Limited (NSX:IQX) OncoTEX Gold Compound Licensing

🕔11/5/2021 9:06:00 AM 3262

iQX Limited (NSX:IQX) is pleased to announce that OncoTEX Inc has received licensing for a gold compound platform technology that induces the body's immune system to destroy cancer cells.

Read Full Article

IQX Limited (NSX:IQX) Portfolio Company Awarded $6.3M Federal Govt Grant

🕔7/9/2021 9:27:00 AM 3726

iQX Limited (NSX:IQX), on behalf of Life Science Biosensor Diagnostics Pty Ltd (LSBD), in which IQX holds 19% equity position, that LSBD's subsidiary GBS today announced it has been awarded a AUD $6.3 million, Australian Federal Government scientific grant.

Read Full Article

IQX Limited (NSX:IQX) Progress of Clinical Programs

🕔4/29/2021 3:20:00 PM 3255

iQX Limited (iQX Ltd) (NSX:IQX) would like to announce that Life Science Biosensor Diagnostics Pty Ltd (LSBD) in which iQX Ltd holds a 19% equity position, has received approval from the Harvard Longwood campus Institutional Review Board (IRB) to commence a clinical validation study to test patient samples from a COVID-19 repository.

Read Full Article

IQX Limited (NSX:IQX) Notice of EGM

🕔6/10/2020 4:16:00 PM 3451

Notice is hereby given that an Extraordinary General Meeting (EGM) of iQX Limited (NSX:IQX) will be held at ParkRoyal Darling Harbour at 10.00am (AEST) on Tuesday 14 July 2020.

Read Full Article

IQX Limited (NSX:IQX) COVID-19 Diagnostic Test With Harvard University

🕔6/9/2020 3:12:00 PM 3374

iQX Limited (iQX Ltd) (NSX:IQX) would like to announce a collaboration agreement between the Wyss Institute for Biologically Inspired Engineering, Harvard University, and Life Science Biosensor Diagnostics Pty Ltd (LSBD), in which iQX Ltd holds a 19% equity position.

Read Full Article
###

6,344 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 3) (Last 30 Days: 28) (Since Published: 6344) 

Company Data

    Headquarters
  • Level 9,85 Castlereagh Street
    Sydney, NSW, 2000
    Australia
  • Telephone
  • +61-2-8239-5400 
  • Principal Sector
  • Biotech 
  • Principal Industry
  • Funds Management 
  • Homepage
  • www.iqxinvestments.com

Company Reports

Social Media